Multiple cytokines, including IL-1β and IFNγ, have been shown to regulate iNOS activation to induce NO production; however, the administration of iNOS inhibitors exacerbates the overwhelming majority of infections [41], [42]. The gene discussed is NOS2; the disease is infection.